ARK Investment Management Discloses 7.7% Stake in Arcturus Therapeutics

TL;DR

**ARK still owns a big chunk of Arcturus, signaling continued institutional interest.**

AI Summary

ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership in Arcturus Therapeutics Holdings Inc. As of December 31, 2023, ARK beneficially owned 2,047,687 shares of Arcturus's common stock, representing 7.7% of the company. This filing indicates a change in ARK's holdings, which is important for investors as it signals a significant institutional investor's continued, albeit potentially adjusted, interest in the pharmaceutical company.

Why It Matters

This filing shows that a major institutional investor, ARK Investment Management, maintains a significant stake in Arcturus Therapeutics, which can influence investor sentiment and stock price due to ARK's prominent market presence.

Risk Assessment

Risk Level: low — This filing is a routine update on institutional ownership and does not inherently introduce new risks, but rather provides transparency.

Analyst Insight

An investor should note ARK's continued significant ownership as a potential indicator of long-term institutional confidence in Arcturus Therapeutics, but also monitor future filings for any changes in their position, which could signal a shift in ARK's investment thesis.

Key Numbers

• 2,047,687 — Shares Beneficially Owned (The total number of Arcturus Therapeutics shares ARK Investment Management LLC holds with sole voting and dispositive power as of December 31, 2023.)
• 7.7% — Percentage of Class (The percentage of Arcturus Therapeutics' common stock beneficially owned by ARK Investment Management LLC, indicating a significant stake.)
• December 31, 2023 — Date of Event (The date as of which the ownership stake was calculated for this filing.)
• January 29, 2024 — Filing Date (The date this amended SC 13G/A was filed with the SEC.)

Key Players & Entities

• ARK Investment Management LLC (company) — the reporting person and institutional investor
• Arcturus Therapeutics Holdings Inc. (company) — the subject company whose securities are being reported
• Delaware, United States (company) — place of organization for ARK Investment Management LLC
• 03 Life Sciences (company) — organization name associated with Arcturus Therapeutics Holdings Inc.
• Cathie Wood (person) — founder and CEO of ARK Investment Management LLC

Forward-Looking Statements

• ARK Investment Management LLC will continue to hold a significant stake in Arcturus Therapeutics Holdings Inc. throughout 2024. (ARK Investment Management LLC) — medium confidence, target: December 31, 2024
• The disclosure of ARK's 7.7% stake will maintain positive investor sentiment for Arcturus Therapeutics Holdings Inc. in the short term. (Arcturus Therapeutics Holdings Inc.) — medium confidence, target: April 30, 2024

FAQ

Filing Documents

• tm244117d9_sc13ga.htm (SC 13G/A) — 49KB
• 0001104659-24-007711.txt ( ) — 51KB

(a) Name of issuer

Item 1(a) Name of issuer: Arcturus Therapeutics Holdings Inc.

(b) Address of issuer's principal executive offices

Item 1(b) Address of issuer's principal executive offices: 10628 Science Center Drive, Suite 250 San Diego, CA 92121

(a) Name of person filing

Item 2(a) Name of person filing: ARK Investment Management LLC

(b) Address or principal business office or, if none,

Item 2(b) Address or principal business office or, if none, residence: ARK Investment Management LLC 200 Central Avenue St. Petersburg, FL 33701

(c) Citizenship

Item 2(c) Citizenship: Delaware, United States

(d) Title of class of securities

Item 2(d) Title of class of securities: Common Stock

(e) CUSIP No

Item 2(e) CUSIP No.: 03969T109

If this statement is filed pursuant to §§ 240.13d-1(b) or

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ CUSIP No. 03969T109 13G Page 4 of 5 Pages

Ownership

Item 4. Ownership (a) Amount beneficially owned: 2,047,687 (b) Percent of class: 7.66% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 2,047,687 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 2,047,687 (iv) Shared power to dispose or to direct the disposition of: 0

Ownership of 5 Percent or Less of a Class

Item 5. Ownership of 5 Percent or Less of a Class. Not applicable.

Ownership of More than 5 Percent on Behalf of Another Person

Item 6. Ownership of More than 5 Percent on Behalf of Another Person. To the knowledge of the Reporting Person, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, a number of the shares which represents more than five percent of the number of outstanding class of the shares.

Identification and Classification of the Subsidiary Which

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 03969T109 13G Page 5 of 5 Pages

Certifications

Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. The reporting persons agree that this statement is filed on behalf of each of them. Dated: January 29, 2024 ARK Investment Management LLC By: /s/ Kellen Carter Name: Kellen Carter Title: Chief Compliance Officer

View Full Filing

View this SC 13G/A filing on SEC EDGAR